Aims: We performed a double-blind, placebo-controlled randomized trial of sertraline in
recently detoxified alcohol-dependent patients with current depressive symptoms. The …

Objective: Long-standing evidence indicates that Alzheimer's disease patients with
behavioral symptoms have a worse prognosis and a more rapid disease progression. The …

Depression has been related to relapsed drinking in alcoholics striving to maintain sobriety.
Treatment with tricyclic antidepressants might reverse or prevent depressive symptoms …

Depression is a common phenomenon among patients with alcohol or drug dependence, as
is evident to any practitioner working with these patients. Numerous studies have …

Background Memantine is a non-competitive N-methyl-d-aspartate receptor antagonist
currently used for the treatment of Alzheimer's disease as an approved indication. However …

Seventy‐two hospitalized patients with alcohol withdrawal symptoms were treated with
either carbamazepine (Tegretol®) or barbital (Diemal) in a randomized, double‐blind trial …

Background: Agitation and aggression in Alzheimer's disease (AD) are amongst the most
serious of neuropsychiatric symptoms, and contribute to poor outcomes and worse quality of …

The effectiveness of 3 antidepressant medications was compared with that of EST in 128
depressed hospitalized patients at 3 state mental hospitals. The results of this double blind …

Over more than 30 years, evidence has accumulated confirming the hypothesis that
norepinephrine and serotonin play pivotal roles in the mechanism of action of …

Escitalopram is the S-enantiomer of citalopram. In this study, we compared the efficacy of
equivalent dosages of escitalopram and citalopram in the treatment of moderate to severe …